Showing results (1581-1590 of 9,116) with videos related to
Sort By:
Pageof 912
Journal of Cellular and Molecular Medicine|June 8, 2026
Superoxide Dismutase-Centered Modulation by Curcumin in Cardiovascular Diseases: Mechanistic Insights and Translational ImplicationsDanial Khayatan, Seyed Mehrad Razavi, Zahra Najafi Arab, et al.Journal of Cellular and Molecular Medicine|June 5, 2026
The NF-κB Signalling Pathway: Mechanisms, Consequences and Therapeutic TargetsBherouz Pourdad, Arash PourdadJournal of Cellular and Molecular Medicine|April 6, 2026
OMICS Profiling Identifies Signatures of Senescence in Osteogenesis Imperfecta Osteoblasts Counteracted by 4-PBARoberta Besio, Elisa Maffioli, Erika Palladino, et al.Journal of Cellular and Molecular Medicine|April 30, 2026
Inhibitory Activity of Conferone on FAK Activity and Glutamine Metabolism in Human Colorectal CancerHien Thi My Ong, Eda Ates, Jaeyong Jung, et al.Journal of Cellular and Molecular Medicine|May 12, 2026
Preliminary Clinical Outcomes of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Chronic Rhinosinusitis With Nasal Polyps: A Case ReportManoochehr Avatef-Fazeli, Gelavizh Rostaminasab, Iman Janghorban Esfahani, et al.Journal of Cellular and Molecular Medicine|April 25, 2026
Advances in CRISPR Base Editing: From Molecular Evolution to Therapeutic Applications in Genomic MedicineMelike Aliciaslan, Ezgi Erbasan, Fulya Erendor, et al.Journal of Cellular and Molecular Medicine|April 16, 2026
Cycloastragenol Inhibits Colorectal Cancer Cell Metastasis via Epithelial-Mesenchymal Transition and the PI3K Signalling PathwayJingRong Miao, PanFeng FengJournal of Cellular and Molecular Medicine|May 14, 2026
Circulating miRNAs Correlate With rIPC-Induced Cardioprotection and Its Impairment in Diabetic Myocardial Infarction via AMPK SignallingYeyi Bai, Bang'e Zhao, Tingting Liu, et al.Journal of Cellular and Molecular Medicine|February 24, 2026
The Role of HER2 and RANK in Breast Cancer and New Therapeutic Approaches With Denosumab, Anti-HER2 Antibodies and ImmunotherapyPanagiotis Sarantis, Aristofania Simatou, Ioanna A Anastasiou, et al.Journal of Cellular and Molecular Medicine|March 12, 2026
The SGLT2 Inhibitor Canagliflozin Promotes β-Cell Regeneration and Restores and Stabilises β-Cell Identity in a Polygenic Model of Severe Early-Onset Type 2 DiabetesIuliana Popescu, Robert C Bunn, Phil Ray, et al.Pageof 912